• 581 Citations
  • 14 h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Review article
2019

Revisiting mTOR inhibitors as anticancer agents

Teng, Q. X., Ashar, Y. V., Gupta, P., Gadee, E., Fan, Y. F., Reznik, S. E., Wurpel, J. N. D. & Chen, Z. S., Oct 2019, In : Drug Discovery Today. 24, 10, p. 2086-2095 10 p.

Research output: Contribution to journalReview article

2 Scopus citations
2018

Repurposing N,N-dimethylacetamide (DMA), a pharmaceutical excipient, as a prototype novel anti-inflammatory agent for the prevention and/or treatment of preterm birth

Gorasiya, S., Mushi, J., Pekson, R., Yoganathan, S. & Reznik, S. E., Jan 1 2018, In : Current pharmaceutical design. 24, 9, p. 989-992 4 p.

Research output: Contribution to journalReview article

4 Scopus citations
2017

Discrepancies in animal models of preterm birth

Manuel, C. R., Ashby, C. R. & Reznik, S. E., Jan 1 2017, In : Current pharmaceutical design. 23, 40, p. 6142-6148 7 p.

Research output: Contribution to journalReview article

3 Scopus citations
2001

Carboxypeptidases from A to Z: Implications in embryonic development and Wnt binding

Reznik, S. E. & Fricker, L. D., Jan 1 2001, In : Cellular and Molecular Life Sciences. 58, 12-13, p. 1790-1804 15 p.

Research output: Contribution to journalReview article

119 Scopus citations